Laurion Capital Management LP Heron Therapeutics, Inc. Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $1,116 - $2,316	496 Added 0.43%	114,817 $287,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $304,093 - $613,903	114,321 New	114,321 $482,000
Q4 2019 Feb 13, 2020	SELL	$17.42 - $26.61 $428,950 - $655,244	-24,624 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$16.36 - $21.39 $402,848 - $526,707	24,624 New	24,624 $456,000
Q2 2019 Aug 13, 2019	SELL	$16.93 - $26.22 $149,932 - $232,204	-8,856 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$23.15 - $28.34 $205,016 - $250,979	8,856 New	8,856 $216,000
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $1.92 Million - $2.79 Million	-87,103 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $2.61 Million - $3.56 Million	87,103 New	87,103 $2.76 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.